Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation

P. Latzin, R. Kraemer (Berne, Switzerland)

Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Session: Gas exchange and paediatric exercise testing
Session type: Thematic Poster Session
Number: 896
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Latzin, R. Kraemer (Berne, Switzerland). Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation. Eur Respir J 2010; 36: Suppl. 54, 896

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011


Cystic fibrosis patients: do they profit from altitiude residence?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006


Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Cystic fibrosis: Heartburn and lung function – ²Too hot to handle²
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012

Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


Long term non invasive positive pressure ventilation is associated with a stabilisation in the decline of lung function in patients with cystic fibrosis
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006


Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis?
Source: Eur Respir J 2006; 28: 96-101
Year: 2006



Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Changes in ventilatory mechanics with increasing disease severity in children and adolesecents with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010

Airway-centered interstitial fibrosis – Two case reports
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005

Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis
Source: Eur Respir J 2001; 17: 712-715
Year: 2001



Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019